NIAID Banner Logo Image

Other Viruses Citation List: November 21 - December 4, 2014

Hepatitis B Virus

1. miR-125b Inhibits Hepatitis B Virus Expression in Vitro through Targeting of the SCNN1A Gene. Zhang, Z., J. Chen, Y. He, X. Zhan, R. Zhao, Y. Huang, H. Xu, Z. Zhu, and Q. Liu. Archives of Virology, 2014. 159(12): p. 3335-3343. PMID[25173609].

[PubMed]. OV_1121-120414.

Hepatitis C Virus

2. Binding Kinetics, Potency, and Selectivity of the Hepatitis C Virus NS3 Protease Inhibitors GS-9256 and Vedroprevir. Barauskas, O., A.C. Corsa, R. Wang, S. Hluhanich, D. Jin, M. Hung, H. Yang, W.E.t. Delaney, and B.E. Schultz. Biochimica et Biophysica Acta, 2014. 1840(12): p. 3292-3298. PMID[25139683].

[PubMed]. OV_1121-120414.


3. Production and Evaluation of Antimycotic and Antihepatitis C Virus Potential of Fusant MERV6270 Derived from Mangrove Endophytic Fungi Using Novel Substrates of Agroindustrial Wastes. El-Gendy, M.M., A.M. El-Bondkly, and S.M. Yahya. Applied Biochemistry and Biotechnology, 2014. 174(8): p. 2674-2701. PMID[25234393].

[PubMed]. OV_1121-120414.


4. Cross-genotypic Examination of Hepatitis C Virus Polymerase Inhibitors Reveals a Novel Mechanism of Action for Thumb Binders. Eltahla, A.A., E. Tay, M.W. Douglas, and P.A. White. Antimicrobial Agents and Chemotherapy, 2014. 58(12): p. 7215-7224. PMID[25246395].

[PubMed]. OV_1121-120414.


5. Anti-interferon-alpha Neutralizing Antibody Induced Telaprevir Resistance under the Interferon-alpha Plus Telaprevir Treatment in Vitro. Kuga, C., H. Enomoto, N. Aizawa, T. Takashima, N. Ikeda, A. Ishii, Y. Sakai, Y. Iwata, H. Tanaka, M. Saito, H. Iijma, and S. Nishiguchi. Biochemical and Biophysical Research Communications, 2014. 454(3): p. 453-458. PMID[25450683].

[PubMed]. OV_1121-120414.


6. Potency and Resistance Analysis of Hepatitis C Virus NS5B Polymerase Inhibitor BMS-791325 on All Major Genotypes. Liu, M., M. Tuttle, M. Gao, and J.A. Lemm. Antimicrobial Agents and Chemotherapy, 2014. 58(12): p. 7416-7423. PMID[25267677].

[PubMed]. OV_1121-120414.


7. NS5A Inhibitors Impair NS5A-Phosphatidylinositol 4-Kinase IIIalpha Complex Formation and Cause a Decrease of Phosphatidylinositol 4-Phosphate and Cholesterol Levels in Hepatitis C Virus-associated Membranes. Reghellin, V., L. Donnici, S. Fenu, V. Berno, V. Calabrese, M. Pagani, S. Abrignani, F. Peri, R. De Francesco, and P. Neddermann. Antimicrobial Agents and Chemotherapy, 2014. 58(12): p. 7128-7140. PMID[25224012].

[PubMed]. OV_1121-120414.


8. Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase. Rigat, K.L., H. Lu, Y.K. Wang, A. Argyrou, C. Fanslau, B. Beno, Y. Wang, J. Marcinkeviciene, M. Ding, R.G. Gentles, M. Gao, L.M. Abell, and S.B. Roberts. The Journal of Biological Chemistry, 2014. 289(48): p. 33456-33468. PMID[25301950].

[PubMed]. OV_1121-120414.


9. Ombitasvir (ABT-267), a Novel NS5A Inhibitor for the Treatment of Hepatitis C. Stirnimann, G. Expert Opinion on Pharmacotherapy, 2014. 15(17): p. 2609-2622. PMID[25347030].

[PubMed]. OV_1121-120414.


10. Sofosbuvir, a Novel Nucleotide Analogue Inhibitor Used for the Treatment of Hepatitis C Virus. Summers, B.B., J.W. Beavers, and O.M. Klibanov. Journal Pharmacology and Pharmacotherapeutics, 2014. 66(12): p. 1653-1666. PMID[25175944].

[PubMed]. OV_1121-120414.

Herpes Simplex Virus 1

11. Spectrum of Activity and Mechanisms of Resistance of Various Nucleoside Derivatives against Gammaherpesviruses. Coen, N., S. Duraffour, D. Topalis, R. Snoeck, and G. Andrei. Antimicrobial Agents and Chemotherapy, 2014. 58(12): p. 7312-7323. PMID[25267682].

[PubMed]. OV_1121-120414.


12. Inhibitors of Nucleotidyltransferase Superfamily Enzymes Suppress Herpes Simplex Virus Replication. Tavis, J.E., H. Wang, A.E. Tollefson, B. Ying, M. Korom, X. Cheng, F. Cao, K.L. Davis, W.S. Wold, and L.A. Morrison. Antimicrobial Agents and Chemotherapy, 2014. 58(12): p. 7451-7461. PMID[25267681].

[PubMed]. OV_1121-120414.

Herpes Simplex Virus 2

13. Prophylactic Treatment with a Novel Bioadhesive Gel Formulation Containing Aciclovir and Tenofovir Protects from HSV-2 Infection. Shankar, G.N. and C. Alt. The Journal of Antimicrobial Chemotherapy, 2014. 69(12): p. 3282-3293. PMID[25139839].

[PubMed]. OV_1121-120414.

Citations from the ISI Web of Knowledge Listings for O.V.

14. Synthesis and anti-HCV Activity of 1-(1',3'-O-Anhydro-3'-C-methyl-beta-D-psicofuranosyl)uracil. Komsta, Z., B. Mayes, A. Moussa, M. Shelbourne, A. Stewart, A.J. Tyrrell, L.L. Wallis, A.C. Weymouth-Wilson, and A. Yurek-George. Tetrahedron Letters, 2014. 55(45): p. 6216-6219. ISI[000344204600015].

[WOS]. OV_1121-120414.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021